Moreover, KLF4 clinical significance was demonstrated in BLCA, BRCA, CESC, LAML, PAAD, PCPG, SKCM, THCA, UCEC, and UCS via ROC analysis (Fig S8 in S1 File). The gene discussed is KLF4; the disease is bladder transitional cell carcinoma.